Register
Login

Trending Topic

abstract blue eye
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

On 28 May 2024, enrolment in phase III clinical trials for sozinibercept in neovascular age-related macular degeneration (nAMD) was completed.1 These trials include two large multicentre, double-masked, randomized controlled trials (RCTs): COAST (OPT-302 with aflibercept in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757636) and ShORe (OPT-302 with ranibizumab in neovascular age-related macular degeneration; ClinicalTrials.gov identifier: NCT04757610).2,3 These trials represent one of the largest phase […]

Thursday 13th June, SOE 2019 – Cataract surgery and visual rehabilitation in AMD patients

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 13th 2019

Coverage of the SOE 2019 symposium Cataract surgery and visual rehabilitation in AMD patients featuring:

Andrzej Grzybowski – Cataract surgery in AMD patients

Silvia Bini – The strategies of fixation in patients with macular degeneration

Silvia Bini – Visual rehabilitation in AMD

Marie-Jose Tassignon – Physics behind the magnifying IOLs

David Keegan – Use of intra-ocular magnifying devices in stable AMD

Filmed in partnership with European Society of Ophthalmology (SOE). See individual presentations for speaker disclosure information.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup